Pulmonx Corporation LUNG
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 88.78M | 87.44M | 88.55M | 90.50M | 91.66M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 88.78M | 87.44M | 88.55M | 90.50M | 91.66M |
| Cost of Revenue | 20.05M | 20.06M | 21.70M | 23.36M | 24.48M |
| Gross Profit | 68.73M | 67.38M | 66.84M | 67.14M | 67.19M |
| SG&A Expenses | 88.75M | 94.33M | 99.26M | 101.31M | 105.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 128.18M | 133.75M | 140.60M | 144.16M | 148.84M |
| Operating Income | -39.41M | -46.31M | -52.06M | -53.66M | -57.18M |
| Income Before Tax | -41.93M | -47.52M | -52.57M | -53.38M | -56.28M |
| Income Tax Expenses | 619.00K | 596.00K | 640.00K | 626.00K | 478.00K |
| Earnings from Continuing Operations | -42.55 | -48.12 | -53.21 | -54.00 | -56.75 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.55M | -48.12M | -53.21M | -54.00M | -56.75M |
| EBIT | -39.41M | -46.31M | -52.06M | -53.66M | -57.18M |
| EBITDA | -38.42M | -45.39M | -51.06M | -52.51M | -55.96M |
| EPS Basic | -1.01 | -1.16 | -1.29 | -1.33 | -1.41 |
| Normalized Basic EPS | -0.62 | -0.71 | -0.80 | -0.82 | -0.87 |
| EPS Diluted | -1.01 | -1.16 | -1.29 | -1.33 | -1.41 |
| Normalized Diluted EPS | -0.62 | -0.71 | -0.80 | -0.82 | -0.87 |
| Average Basic Shares Outstanding | 168.95M | 166.71M | 164.67M | 162.73M | 160.90M |
| Average Diluted Shares Outstanding | 168.95M | 166.71M | 164.67M | 162.73M | 160.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |